The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Mutations resulting in reduced signaling of the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis are associated with increased life- and healthspan across model organisms. Similar findings have been noted in human cohorts with functional mutations in the somatotropic axis, suggesting that this pathway may also be relevant to human aging and protection from age-related diseases. While epidemiological data indicate that low circulating IGF-1 level may protect aging populations from cancer, results remain inconclusive regarding most other diseases. We propose that studies in humans and animals need to consider differences in sex, pathway function, organs, and time-specific effects of GH/IGF-1 signaling in order to better define the role of the somatotropic axis in aging. Agents that modulate signaling of the GH/IGF-1 pathway are available for human use, but before they can be implemented in clinical studies that target aging and age-related diseases, researchers need to address the challenges discussed in this Review.

Original languageEnglish (US)
Pages (from-to)980-989
Number of pages10
JournalCell Metabolism
Volume23
Issue number6
DOIs
StatePublished - Jun 14 2016

Fingerprint

Somatomedins
Growth Hormone
Mutation
Insulin-Like Growth Factor I
Sex Characteristics
Research Personnel
Population
Neoplasms

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Physiology

Cite this

@article{e621c8592b7e4f7abf6b9f02f849a719,
title = "The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research",
abstract = "Mutations resulting in reduced signaling of the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis are associated with increased life- and healthspan across model organisms. Similar findings have been noted in human cohorts with functional mutations in the somatotropic axis, suggesting that this pathway may also be relevant to human aging and protection from age-related diseases. While epidemiological data indicate that low circulating IGF-1 level may protect aging populations from cancer, results remain inconclusive regarding most other diseases. We propose that studies in humans and animals need to consider differences in sex, pathway function, organs, and time-specific effects of GH/IGF-1 signaling in order to better define the role of the somatotropic axis in aging. Agents that modulate signaling of the GH/IGF-1 pathway are available for human use, but before they can be implemented in clinical studies that target aging and age-related diseases, researchers need to address the challenges discussed in this Review.",
author = "Sofiya Milman and Huffman, {Derek M.} and Nir Barzilai",
year = "2016",
month = "6",
day = "14",
doi = "10.1016/j.cmet.2016.05.014",
language = "English (US)",
volume = "23",
pages = "980--989",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - The Somatotropic Axis in Human Aging

T2 - Framework for the Current State of Knowledge and Future Research

AU - Milman, Sofiya

AU - Huffman, Derek M.

AU - Barzilai, Nir

PY - 2016/6/14

Y1 - 2016/6/14

N2 - Mutations resulting in reduced signaling of the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis are associated with increased life- and healthspan across model organisms. Similar findings have been noted in human cohorts with functional mutations in the somatotropic axis, suggesting that this pathway may also be relevant to human aging and protection from age-related diseases. While epidemiological data indicate that low circulating IGF-1 level may protect aging populations from cancer, results remain inconclusive regarding most other diseases. We propose that studies in humans and animals need to consider differences in sex, pathway function, organs, and time-specific effects of GH/IGF-1 signaling in order to better define the role of the somatotropic axis in aging. Agents that modulate signaling of the GH/IGF-1 pathway are available for human use, but before they can be implemented in clinical studies that target aging and age-related diseases, researchers need to address the challenges discussed in this Review.

AB - Mutations resulting in reduced signaling of the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis are associated with increased life- and healthspan across model organisms. Similar findings have been noted in human cohorts with functional mutations in the somatotropic axis, suggesting that this pathway may also be relevant to human aging and protection from age-related diseases. While epidemiological data indicate that low circulating IGF-1 level may protect aging populations from cancer, results remain inconclusive regarding most other diseases. We propose that studies in humans and animals need to consider differences in sex, pathway function, organs, and time-specific effects of GH/IGF-1 signaling in order to better define the role of the somatotropic axis in aging. Agents that modulate signaling of the GH/IGF-1 pathway are available for human use, but before they can be implemented in clinical studies that target aging and age-related diseases, researchers need to address the challenges discussed in this Review.

UR - http://www.scopus.com/inward/record.url?scp=84975451703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975451703&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2016.05.014

DO - 10.1016/j.cmet.2016.05.014

M3 - Article

C2 - 27304500

AN - SCOPUS:84975451703

VL - 23

SP - 980

EP - 989

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 6

ER -